Michael P Vitek Selected Research

Michael P Vitek Research Topics

Disease

26	Alzheimer Disease (Alzheimer's Disease) 04/2015 - 04/2002
11	Brain Injuries (Brain Injury) 03/2023 - 03/2005
11	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 12/2003
10	Inflammation (Inflammations) 03/2023 - 12/2003
10	Amyloid Plaque 12/2012 - 04/2002
9	Neoplasms (Cancer) 12/2023 - 10/2011
8	Neuroinflammatory Diseases 01/2018 - 07/2005
7	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2018 - 01/2006
5	Brain Edema (Cerebral Edema) 01/2017 - 01/2006
4	Infections 03/2023 - 02/2011
4	Cerebral Hemorrhage 01/2016 - 02/2009
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2010 - 05/2002
3	Brain Ischemia (Cerebral Ischemia) 01/2016 - 02/2009
3	Multiple Sclerosis 04/2013 - 12/2003
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2012 - 09/2006
3	Cognitive Dysfunction 02/2011 - 07/2004
3	Brain Contusion 12/2010 - 07/2007
3	Dementia (Dementias) 08/2007 - 06/2002
2	Malnutrition (Nutritional Deficiencies) 03/2023 - 01/2014
2	Body Weight (Weight, Body) 10/2017 - 07/2014
2	Edema (Dropsy) 01/2016 - 02/2009
2	Leukemia 04/2014 - 01/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2013 - 09/2006
2	Infarction (Infarctions) 03/2013 - 02/2009
2	Ischemia 03/2013 - 06/2005
2	Hematoma 04/2012 - 03/2012
2	Sepsis (Septicemia) 02/2011 - 06/2008
2	Nervous System Diseases (Neurological Disorders) 09/2009 - 12/2008
2	Stroke (Strokes) 02/2009 - 09/2002
2	Wounds and Injuries (Trauma) 10/2007 - 08/2007
2	Closed Head Injuries 03/2005 - 09/2002
2	Encephalitis (Encephalitis, Rasmussen) 03/2005 - 12/2003
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2022
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022
1	Cysts 01/2022
1	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2022
1	Disease Progression 01/2022
1	Squamous Cell Carcinoma of Head and Neck 09/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2016
1	Prostatic Neoplasms (Prostate Cancer) 11/2015

Drug/Important Bio-Agent (IBA)

33	ApolipoproteinsIBA 03/2023 - 03/2005
33	Apolipoproteins E (ApoE)IBA 03/2023 - 06/2002
32	Peptides (Polypeptides)IBA 03/2023 - 04/2002
21	Proteins (Proteins, Gene)FDA Link 09/2020 - 04/2002
14	COG1410IBA 01/2022 - 07/2007
13	Apolipoprotein E4IBA 01/2014 - 06/2002
12	Amyloid beta-PeptidesIBA 12/2012 - 04/2002
11	Amyloid (Amyloid Fibrils)IBA 08/2014 - 03/2004
8	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018 - 02/2011
5	Apolipoprotein E3IBA 01/2014 - 01/2006
4	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2018 - 03/2005
4	Oncogene Proteins (Oncogene Protein)IBA 12/2016 - 10/2011
4	Protein Isoforms (Isoforms)IBA 03/2013 - 06/2002
3	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 01/2017
3	Nitric Oxide Synthase (NO Synthase)IBA 12/2012 - 02/2008
3	Matrix Metalloproteinases (MMPs)IBA 12/2012 - 03/2004
3	Amino Acids FDA Link 01/2012 - 06/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2011 - 09/2006
3	CytokinesIBA 02/2011 - 09/2006
3	Messenger RNA (mRNA)IBA 02/2011 - 09/2006
3	tau Proteins (tau Protein)IBA 02/2011 - 04/2002
2	LDL Receptors (LDL Receptor)IBA 03/2023 - 01/2012
2	EnzymesIBA 01/2018 - 03/2004
2	Neuroprotective AgentsIBA 01/2018 - 01/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2016 - 06/2014
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016 - 12/2012
2	AndrogensIBA 11/2015 - 07/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2011 - 02/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2023
1	Protein SIBA 03/2023
1	InflammasomesIBA 01/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	sphingosine kinaseIBA 09/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2020
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 12/2018
1	Blood Glucose (Blood Sugar)IBA 10/2017
1	Insulin (Novolin)FDA Link 10/2017
1	CholesterolIBA 10/2017
1	Triglycerides (Triacylglycerol)IBA 10/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Serine (L-Serine)FDA Link 12/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016
1	Tyrosine (L-Tyrosine)FDA Link 12/2016
1	Threonine (L-Threonine)FDA Link 12/2016
1	Phosphotransferases (Kinase)IBA 12/2016
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 12/2016
1	Evans Blue (Blue, Evans)FDA Link 01/2016
1	Coloring Agents (Dyes)IBA 01/2016
1	enzalutamideIBA 11/2015
1	Hormones (Hormone)IBA 11/2015
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2015

Therapy/Procedure

10	Therapeutics 12/2023 - 07/2004
2	Drug Therapy (Chemotherapy) 01/2018 - 07/2012
2	Intravenous Injections 02/2009 - 03/2005
1	Aftercare (After-Treatment) 09/2020
1	Castration 11/2015